Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer

被引：13
作者：
Fan N.-J. [1 ,2 ]
Kang R. [1 ]
Ge X.-Y. [1 ]
Li M. [3 ]
Liu Y. [4 ]
Chen H.-M. [5 ]
Gao C.-F. [1 ]
机构：
[1] Institute of Anal-colorectal Surgery, Luoyang
[2] The General Hospital of Jinan Military Region, Jinan
[3] Respiration Department, Luoyang
[4] Neuro- Surgery Department, Luoyang
[5] Clinical Laboratory, The First People's Hospital of the City of Luoyang, Luoyang
来源：
Diagnostic Pathology | / 9卷 / 1期
关键词：
Alpha-2-HS-glycoprotein; Biological markers; Colorectal neoplasms; Diagnosis; Proteomics; Tubulin beta chain;
D O I：
10.1186/1746-1596-9-53
中图分类号：
学科分类号：
摘要：
Background: Colorectal cancer (CRC) remains a major worldwide cause of cancer-related morbidity and mortality largely due to the insidious onset of the disease. The current clinical procedures utilized for disease diagnosis are invasive, unpleasant, and inconvenient. Hence, the need for simple blood tests that could be used for the early detection is crucial for its ultimate control and prevention.Methods: The present work is a case-control study focused on proteomic analysis of serum of healthy volunteers and CRC patients by the ClinProt profiling technology based on mass spectrometry. This approach allowed to identifying a pattern of proteins/peptides able to differentiate the studied populations. Moreover, some of peptides differentially expressed in the serum of patients as compared to healthy volunteers were identified by LTQ Orbitrap XL.Results: A Quick Classifier Algorithm was used to construct the peptidome patterns (m/z 1208, 1467, 1505, 1618, 1656 and 4215) for the identification of CRC from healthy volunteers with accuracy close to 100% (>CEA, P < 0.05). Peaks at m/z 1505 and 1618 were identified as alpha-2-HS-glycoprotein precursor and tubulin beta chain, respectively.Conclusions: Alpha-2-HS-glycoprotein precursor and tubulin beta chain could be involved in the pathogenesis of CRC and perform as potential serology diagnosis biomarker. © 2014 Fan et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 63 条
[1]  
Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D., Global cancer statistics, CA Cancer J Clin, 61, pp. 69-90, (2011)
[2]  
Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010, CA Cancer J Clin, 60, pp. 277-300, (2010)
[3]  
Ciccolallo L., Capocaccia R., Coleman M.P., Berrino F., Coebergh J.W., Damhuis R.A., Faivre J., Martinez-Garcia C., Moller H., Ponz de Leon M., Launoy G., Raverdy N., Williams E.M., Gatta G., Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery, Gut, 54, pp. 268-273, (2005)
[4]  
Engwegen J.Y., Helgason H.H., Cats A., Harris N., Bonfrer J.M., Schellens J.H., Beijnen J.H., Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry, World J Gastroenterol, 12, pp. 1536-1544, (2006)
[5]  
Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., Jemal A., Schymura M.J., Lansdorp-Vogelaar I., Seeff L.C., Van Ballegooijen M., Goede S.L., Ries L.A., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, pp. 544-573, (2010)
[6]  
Smith R.A., Cokkinides V., Brooks D., Saslow D., Shah M., Brawley O.W., Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening, CA Cancer J Clin, 61, pp. 8-30, (2011)
[7]  
Ang C.S., Phung J., Nice E.C., The discovery and validation of colorectal cancer biomarkers, Biomed Chromatogr, 25, pp. 82-99, (2011)
[8]  
Ahlquist D.A., Molecular detection of colorectal neoplasia, Gastroenterology, 138, pp. 2127-2139, (2010)
[9]  
Yatabe J., Yatabe M.S., Ishibashi K., Nozawa Y., Sanada H., Early detection of colon cancer by amino acid profiling using AminoIndex technology: a case report, Diagn Pathol, 8, (2013)
[10]  
Chen C., Wang L., Liao Q., Huang Y., Ye H., Chen F., Xu L., Ye M., Duan S., Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer, Diagn Pathol, 8, (2013)
1234567